Lucid opens second office
July 9, 2014Medical Communications CME, lucid
UK medical education firm Lucid has opened a second office in Hammersmith, London. In addition to Lucid Towers, Beaconsfield, it now …
Boehringer blood cancer drug scores in Phase II
July 9, 2014Research and Development, Sales and Marketing Boehringer, blood, giotrif, leukaemia, volasertib
Less than a year after securing its first cancer drug on the market with Giotrif, Boehringer has taken another decisive …
AbbVie makes fourth Shire offer
July 9, 2014Sales and Marketing AbbVie, Abbott, Shire, buyout, merger
The AbbVie/Shire takeover saga rumbles on, with AbbVie raising its bid for the Ireland-based biopharma specialist to $51.5 billion. The …
Clark Health Communications hires account director
July 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clark Health Communications, chc, newman
Clark Health Communications (CHC) has recruited account director Sarah Newman as its first full-time employee to help manage the agency’s …
Telemedicine EU market ‘expected to triple’ by 2020
July 8, 2014Medical Communications, Sales and Marketing Europe, Frost & Sullivan, analysts, telemedicine
The telemedicine market in Europe is poised for rapid growth and can help keep overall healthcare costs down, according to …
UDG Healthcare buys Galliard and Nyxeon for £13m
July 8, 2014Medical Communications Galliard and Nyxeon, udg healthcare
UDG Healthcare has acquired the specialist healthcare and scientific public relations businesses Galliard and Nyxeon. The deal has been secured …
Cameron’s antibiotics plan not enough
July 8, 2014Research and Development, Sales and Marketing Antibiotics, BBC, NHS, UK, david cameron, governement
UK prime minister David Cameron’s reaction to antibiotic resistance is not urgent enough and doctors are continuing to prescribe antibiotics …
World’s first anti-PD-1 therapy approved
July 8, 2014Research and Development, Sales and Marketing BMS, Cancer, melanoma, nivolumab, ono, opdivo
Ono Pharmaceutical has been given the world’s first licence for a new type of cancer treatment on which many researchers’ …
New appointments at NHS England
July 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, NHS Commissioning, NHS England, stevens
NHS England chief executive Simon Stevens has confirmed a number of senior appointments to the organisation. Dr Mahiben Maruthappu has …
GSK manufacturing woes continue
July 8, 2014Manufacturing and Production Canada, FDA, GSK, Paxil, Vaccine, manufacturing
Health Canada has told GlaxoSmithKline that it wants to see the firm fix major problems at the country’s only flu …
Xellia expands in US with Fresenius Kabi buy
July 8, 2014Manufacturing and Production Fresenius Kabi, xellia
Anti-infective treatment provider Xellia has acquired Fresenius Kabi’s dedicated freeze-dried vial manufacturing facility in the US. The deal also includes …
Scottish Medicines Consortium disappoints Celgene
July 8, 2014Sales and Marketing Celgene, SMC, Scottish Medicines Consortium, imnovid, myeloma
Celgene admitted it is ‘disappointed’ with the Scottish Medicines Consortium decision not to recommend blood cancer therapy Imnovid for patients …
New director for Cello Health Insight
July 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, Kantar Health, marie innes
Healthcare market research agency Cello Health Insight has appointed Marie Innes as director. Based in the firm’s London head office …
Rise in diabetes ‘alarming’
July 7, 2014Sales and Marketing NHS, diabetes, nhs scotland, type 2
NHS Scotland has spent around £230 million on diabetes and obesity drugs in the past three years, according to data …
Mekinist shown EU green light
July 7, 2014Sales and Marketing CHMP, Cancer, GSK, Tafinlar, braf, mekinist, melanoma
The European Commission has given GlaxoSmithKline’s melanoma drug Mekinist the thumbs-up following a positive opinion in April from the European …
Alynlam secures fomer Pfizer head
July 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, alynlam, amy schulman
US biotech firm Alynlam has elected Pfizer’s former executive VP and general counsel Amy Schulman to its board of directors. …
Spectrum wins FDA approval for rare cancer drug
July 4, 2014Research and Development, Sales and Marketing Beleodaq, Cancer, FDA, Spectrum, non-Hodgkin lymphoma
In an expedited review the FDA has approved a new cancer drug from Spectrum Pharmaceuticals to treat a rare cancer …
FDA clears St. Jude Medical
July 4, 2014Manufacturing and Production, Sales and Marketing CardioMEMS, FDA, california, st jude medical
US medical device manufacturer St. Jude Medical has been given a clean bill of health by the Food and Drug …
Unison warns of ‘dangerous’ £1 billion NHS tender
July 4, 2014Sales and Marketing CCG, England, NHS, commissioning, unison
A row is bubbling over the provision of health services in Staffordshire after a trade union accused four NHS clinical …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
